These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 21376233)

  • 1. Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase.
    Sun T; Aceto N; Meerbrey KL; Kessler JD; Zhou C; Migliaccio I; Nguyen DX; Pavlova NN; Botero M; Huang J; Bernardi RJ; Schmitt E; Hu G; Li MZ; Dephoure N; Gygi SP; Rao M; Creighton CJ; Hilsenbeck SG; Shaw CA; Muzny D; Gibbs RA; Wheeler DA; Osborne CK; Schiff R; Bentires-Alj M; Elledge SJ; Westbrook TF
    Cell; 2011 Mar; 144(5):703-18. PubMed ID: 21376233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer.
    Nair A; Chung HC; Sun T; Tyagi S; Dobrolecki LE; Dominguez-Vidana R; Kurley SJ; Orellana M; Renwick A; Henke DM; Katsonis P; Schmitt E; Chan DW; Li H; Mao S; Petrovic I; Creighton CJ; Gutierrez C; Dubrulle J; Stossi F; Tyner JW; Lichtarge O; Lin CY; Zhang B; Scott KL; Hilsenbeck SG; Sun J; Yu X; Osborne CK; Schiff R; Christensen JG; Shields DJ; Rimawi MF; Ellis MJ; Shaw CA; Lewis MT; Westbrook TF
    Nat Med; 2018 May; 24(4):505-511. PubMed ID: 29578538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of PTPN12 Stimulates Progression of ErbB2-Dependent Breast Cancer by Enhancing Cell Survival, Migration, and Epithelial-to-Mesenchymal Transition.
    Li J; Davidson D; Martins Souza C; Zhong MC; Wu N; Park M; Muller WJ; Veillette A
    Mol Cell Biol; 2015 Dec; 35(23):4069-82. PubMed ID: 26391955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low expression of tyrosine-protein phosphatase nonreceptor type 12 is associated with lymph node metastasis and poor prognosis in operable triple-negative breast cancer.
    Wu MQ; Hu P; Gao J; Wei WD; Xiao XS; Tang HL; Li X; Ge QD; Jia WH; Liu RB; Xie XM
    Asian Pac J Cancer Prev; 2013; 14(1):287-92. PubMed ID: 23534739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching of the substrate specificity of protein tyrosine phosphatase N12 by cyclin-dependent kinase 2 phosphorylation orchestrating 2 oncogenic pathways.
    Li H; Yang D; Ning S; Xu Y; Yang F; Yin R; Feng T; Han S; Guo L; Zhang P; Qu W; Guo R; Song C; Xiao P; Zhou C; Xu Z; Sun JP; Yu X
    FASEB J; 2018 Jan; 32(1):73-82. PubMed ID: 28842430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein tyrosine phosphatase non-receptor type 12 suppresses tumor progression in osteosarcoma cells.
    Wang X; Wang X; Lai J; Xu W; Zhu W; Chen G
    J Orthop Sci; 2023 Mar; 28(2):468-475. PubMed ID: 35063332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological significance of PTPN12 expression in human breast cancer.
    Xunyi Y; Zhentao Y; Dandan J; Funian L
    Braz J Med Biol Res; 2012 Dec; 45(12):1334-40. PubMed ID: 23044628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine phosphatases in the HER2-directed motility of ovarian cancer cells: Involvement of PTPN12, ERK5 and FAK.
    Villa-Moruzzi E
    Anal Cell Pathol (Amst); 2011; 34(3):101-12. PubMed ID: 21483099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTPN12 controls PTEN and the AKT signalling to FAK and HER2 in migrating ovarian cancer cells.
    Villa-Moruzzi E
    Mol Cell Biochem; 2013 Mar; 375(1-2):151-7. PubMed ID: 23212450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTPN12 Affects Nasopharyngeal Carcinoma Cell Proliferation and Migration Through Regulating EGFR.
    Lin Q; Wang H; Lin X; Zhang W; Huang S; Zheng Y
    Cancer Biother Radiopharm; 2018 Mar; 33(2):60-64. PubMed ID: 29634414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic regulation of protein tyrosine phosphatase PTPN12 in triple-negative breast cancer.
    Thummuri D; Kumar S; Surapaneni SK; Tikoo K
    Life Sci; 2015 Jun; 130():73-80. PubMed ID: 25817229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in the correlation between PTPN12 gene expression and human tumors.
    Huo YH; Wang YN; Meng LB; Zhang AL; Liu B
    Medicine (Baltimore); 2020 Jun; 99(24):e20445. PubMed ID: 32541467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTPN12 promotes resistance to oxidative stress and supports tumorigenesis by regulating FOXO signaling.
    Harris IS; Blaser H; Moreno J; Treloar AE; Gorrini C; Sasaki M; Mason JM; Knobbe CB; Rufini A; Hallé M; Elia AJ; Wakeham A; Tremblay ML; Melino G; Done S; Mak TW
    Oncogene; 2014 Feb; 33(8):1047-54. PubMed ID: 23435421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.
    Cao X; Li Y; Luo RZ; He LR; Yang J; Zeng MS; Wen ZS
    Ann Thorac Surg; 2012 May; 93(5):1674-80. PubMed ID: 22429674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic Oxidation of PTPN12 Underlies ABL1 Phosphorylation in Hereditary Leiomyomatosis and Renal Cell Carcinoma.
    Xu Y; Taylor P; Andrade J; Ueberheide B; Shuch B; Glazer PM; Bindra RS; Moran MF; Linehan WM; Neel BG
    Cancer Res; 2018 Dec; 78(23):6539-6548. PubMed ID: 30297534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer.
    Weidemann SA; Sauer C; Luebke AM; Möller-Koop C; Steurer S; Hube-Magg C; Büscheck F; Höflmayer D; Tsourlakis MC; Clauditz TS; Simon R; Sauter G; Göbel C; Lebok P; Dum D; Fraune C; Kind S; Minner S; Izbicki J; Schlomm T; Huland H; Heinzer H; Burandt E; Haese A; Graefen M; Heumann A
    BMC Cancer; 2019 Oct; 19(1):944. PubMed ID: 31606028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of dendritic cell migration, T cell-dependent immunity, and autoimmunity by protein tyrosine phosphatase PTPN12 expressed in dendritic cells.
    Rhee I; Zhong MC; Reizis B; Cheong C; Veillette A
    Mol Cell Biol; 2014 Mar; 34(5):888-99. PubMed ID: 24366546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A missense variant in PTPN12 associated with the risk of colorectal cancer by modifying Ras/MEK/ERK signaling.
    Shen N; Li L; Xu W; Tian J; Yang Y; Zhu Y; Gong Y; Ke J; Gong J; Chang J; Zhong R; Miao X
    Cancer Epidemiol; 2019 Apr; 59():109-114. PubMed ID: 30731403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying the role of PTPN12 expression in predicting the efficacy of capecitabine to neoadjuvant chemotherapy in breast cancer treatment.
    Wang YY; Liu H; Mao XY; Jin F; Ma B; Jiang JY; Cao Y
    Eur Rev Med Pharmacol Sci; 2016 Aug; 20(16):3400-9. PubMed ID: 27608899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of tyrosine-protein phosphatase nonreceptor type 12 expression in nasopharyngeal carcinoma.
    Zhang XK; Xu M; Chen JW; Zhou F; Ling YH; Zhu CM; Yun JP; Cai MY; Luo RZ
    Tumour Biol; 2015 Jul; 36(7):5201-8. PubMed ID: 25663493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.